Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope

Biotechnology Journal

Volumn 3, Issue 11, 2008, Pages 1429-1436

  Kazaks, Andris ^a   Balmaks, Reinis ^a,b   Voronkova, Tatyana ^a   Ose, Velta ^a   Pumpens, Paul ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b CHILDREN'S CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

CpG packaging; Melanoma; Tumor antigens; Vaccines; Virus like particles

Indexed keywords

ANTI TUMORS; BINDING AFFINITIES; CORE PROTEINS; CPG PACKAGING; CYTOTOXIC T LYMPHOCYTES; DNA-BINDING PROPERTIES; DOUBLE-STRANDED DNAS; ESCHERICHIA COLI CELLS; GENES ENCODING; GERMLINE GENES; HEPATITIS B VIRUS; HEPATITIS-B; HUMAN LEUKOCYTE ANTIGENS; IN-VITRO; IN-VIVO; MELANOMA; OLIGODEOXYNUCLEOTIDES; SINGLE-STRANDED DNAS; TUMOR ANTIGENS; TUMOR REGRESSIONS; TUMOR VACCINES; VIRUS-LIKE PARTICLES;

AMINES; BINDING ENERGY; DNA; ESCHERICHIA COLI; GENES; NUCLEIC ACIDS; PURIFICATION; TUMORS; VACCINES; VIRUSES;

ANTIGENS;

CORE PROTEIN; CPG OLIGODEOXYNUCLEOTIDE; DEOXYRIBONUCLEASE; DNA; DOUBLE STRANDED DNA; EPITOPE; HLA A1 ANTIGEN; HLA B35 ANTIGEN; MELANOMA ANTIGEN 3; MELANOMA VACCINE; SINGLE STRANDED DNA;

ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; DNA BINDING; ESCHERICHIA COLI; GENE EXPRESSION; HEPATITIS B VIRUS; IMMUNOGENICITY; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN MOTIF; RECOMBINANT GENE; TUMOR REGRESSION; VIRUS LIKE AGENT;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; CANCER VACCINES; CLONING, MOLECULAR; CPG ISLANDS; EPITOPES, T-LYMPHOCYTE; HEPATITIS B CORE ANTIGENS; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HEPATITIS B VIRUS;

EID: 62549124523     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200800160     Document Type: Article

References (45)

1. Haas, G. G. Jr., D'Cruz, O. J., De Bault, L. E., Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am. J. Reprod. Immunol. Microbiol. 1988, 18, 47-51.
2. Chomez, P., De Backer, O., Bertrand, M., De Plaen, E. et al., An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 2001, 61, 5544-5551.
3. De Smet, C., De Backer O., Faraoni, I., Lurquin, C. et al., The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA 1996, 93, 7149-7153.
4. Brasseur, F., Rimoldi, D., Lienard, D., Lethe, B. et al.. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer 1995, 63, 375-380.
5. Gaugler, B., van den Eynde, B., van der Bruggen, P., Romero, P. et al., Human gene MAGE-3 codes for an antigen recognized on melanoma by autologous cytalytic T lymphocytes. J. Exp. Med. 1994, 179, 921-930.
6. Schultz, E. S., Zhang, Y., Knowles, R., Tine, J. et al., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes. Tissue Antigens 2001, 57, 103-109.
7. Marsh, S. G. E., Parham, P., Barber, L. D. (Eds.). The HLA Facts Book, Academic Press, San Diego 2000.
8. Marchand, M., van Baren, N., Weynants, P., Brichard, V. et al., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 1999, 80, 219-230.
9. Thurner, B., Haendle, I., Röder, C., Dieckmann, D. et al., Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 1999, 190, 1669-1678.
10. van Baren, N., Bonnet, M. C., Dreno, B., Khammari, A. et al., Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells. J. Clin. Oncol. 2005, 23, 9008-9021.
11. Pumpens, P., Grens. E., Artificial genes for chimeric virus-like particles, in: Khudyakov, Y. (Ed.), Artificial DNA: Methods and Applications, CRC Press. Boca Raton 2002, pp. 249-327.
12. Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K. et al., The influence of antigen organization on B cell responsiveness. Science 1993, 262, 1448-1451.
13. Pumpens, P., Grens, E., HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 2001, 44, 98-114.
14. Pumpens, P., Ulrich, R., Sasnauskas, K., Kazaks, A. et al., Construction of novel vaccines on the basis of the virus-like particles. Hepatitis B virus proteins as vaccine carriers, in: Khudyakov, Y. (Ed.). Medicinal Protein Engineering, CRC Press, Boca Raton 2008, pp. 205-248.
15. Chisari, F. V., Ferrari, C., Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995, 13, 29-60.
16. Milich, D. R., McLachlan, A., The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 1986, 234, 1398-1401.
17. Fehr, T., Skrastina, D., Pumpens, P., Zinkernagel, R. M., T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. USA 1998, 95, 9477-9481.
18. Milich, D. R., Schödel, F., Hughes, J. L., Jones, J. E. Peterson, D. L., The hepatitis B virus core and e antigens elicit differentTh cell subset:Antigen structure can affect Th cell phenotype. J. Virol. 1997, 71, 2192-2201.
19. Kline, J. N., Krieg, A. M., CpG oligodeoxynucleotides. in: Hansel, T.T., Barnes, P.J. (Eds.). New Drugs for Asthma, Allergy and COPD, Progress in Respiratory Research, vol. 31, Basel, Karger 2001, pp. 229-232.
20. Krieg, A. M., Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 2006, 5, 471-484.
21. Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A. et al., Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J. Immunol. 2004, 172, 1777-1785.
22. Bichko, V., Pushko, P., Dreilina, D., Pumpen, P. Gren, E., Subtype ayw variant of hepatitis B virus. DNA primary structure analysis. FEBS Lett. 1985, 185, 208-212.
23. Borisova, G. P., Pumpen, P. P., Bychko, V. V., Pushko, P. M. et al., Structure and expression in Escherichia coli cells of the core antigen gene of the human hepatitis B virus (HBV). Dokl. Akad. Nauk SSSR (in Russian) 1984, 279, 1245-1249.
24. Sambrook, J., Fritsch, E. F., Maniatis. T. (Eds.). Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1989.
25. + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J. Clin. Invest. 2005, 115, 739-746.
26. Barr, S. M., Keck, K., Aposhian, H. V., Cell-free assembly of a polyoma-like particle from empty capsids and DNA. Virology 1979, 96, 656-659.
27. Birnbaum, F., Nassal, M., Hepatitis B virus nucleocapsid assembly: Primary structure requirements in the core protein. J. Virol. 1990, 64, 3319-3330.
28. Zlotnick, A., Cheng, N., Stahl, S. J., Conway J. F. et al., Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: Implications for morphogenesis and organization of encapsidated RNA. Proc. Natl. Acad. Sci. USA 1997, 94, 9556-9561.
29. Wynne, S. A., Crowther, R. A., Leslie, A. G. W., The crystal structure of the human hepatitis B virus capsid. Mol. Cell 1999, 3, 771-780.
30. Schödel, F., Moriarty, A. M., Peterson, D. L., Zheng, J.A. et al., The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 1992, 66, 106-114.
31. Borisova, G., Arya, B., Dislers, A., Borschukova, O. et al., Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen. J. Virol. 1993, 67, 3696-3701.
32. Kratz, P., Bötcher, B., Nassal, M., Native display of complete foreign domains on the surface of hepatitis B virus capsids. Proc. Natl., Acad. Sci. USA 1999, 96, 1915-1920.
33. Koletzki, D., Biel, S. S., Meisel, H., Nugel, E. et al., HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol. Chem. 1999, 380, 325-333.
34. Beterams, G., Böttcher, B., Nassal, M., Packaging of up to 240 subunits of a 17-kDa nuclease into the interior of recombinant hepatitis B virus capsids. FEBS Lett. 2000, 481, 169-176.
35. Bergmann, C. C., Yao, Q., Ho, C. K., Buckwold, S. L., Flanking residues alter antigenicity and immunogenicity of multiunit CTL epitopes. J. Immunol. 1996, 157, 3242-3249.
36. Mylin, L. M., Context-dependent immunogenicity of an S206G-substituted H-2Db-restricted simian virus 40 large T antigen epitope I variant. J. Immunol. 1999, 162, 2171-2179.
37. Karpenko, L. I., Ivanisenko, V. A., Pika, I. A., Chikaev, N. A. et al., Insertion of foreign epitopes in HBcAg: How to make the chimeric particle assemble, Amino Acids 2000, 18, 329-337.
38. Summers, J., Mason, W. S., Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982, 29, 403-415.
39. Hatton, T., Zhou, S., Standring, D. N., RNA- and DNA-binding activities in hepatitis B virus capsid protein: A model for their roles in viral replication. J. Virol. 1992, 66, 5232-5241.
40. Borisova, G., Borschukova, O., Skrastina, D., Dislers, A. et al., Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biol. Chem. 1999, 380, 315-324.
41. Kazaks, A., Borisova, G., Cvetkova, S., Kovalevska, L. et al., Mosaic hepatitis B core particles presenting complete preS sequence of viral envelope on their surface. J. Gen. Virol. 2004, 85, 2665-2670.
42. Sparwasser, T., Hultner, L., Koch, E. S., Luz, A. et al., Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J. Immunol. 1999, 162, 2368-2374.
43. Forstova, J., Krauzewicz, N., Sandig, V., Elliott, J. et al., Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum. Gene Ther. 1995, 6, 297-306.
44. Voronkova, T., Kazaks, A., Ose, V., Özel, M. et al., Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells. Virus Genes 2007, 34, 303-314.
45. Kazaks, A., Voronkova, T., Papillomavirus-derived virus-like particles, in: Khudyakov, Y. (Ed.). Medicinal Protein Engineering CRC Press, Boca Raton 2008, pp. 277-297.